TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9501030
log Bayes Factor = 63.1289
Chromosome 6   position 30,799,399  (GRCh37) Explore rs9501030 on Ensembl!
Variant rs9501030 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.001 0.999
E10.9 Without complications
0.000 0.002 0.998
L40.0 Psoriasis vulgaris
0.997 0.003 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.010 0.990
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.015 0.985
E10-E14 Diabetes mellitus
0.000 0.015 0.985
E10.4 With neurological complications
0.000 0.043 0.957
E10.3 With ophthalmic complications
0.000 0.068 0.932
E07 Other disorders of thyroid
0.000 0.084 0.916
E50-E64 Other nutritional deficiencies
0.000 0.095 0.905
E07.9 Disorder of thyroid, unspecified
0.000 0.121 0.879
E10.5 With peripheral circulatory complications
0.000 0.122 0.878
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.136 0.864
E10.1 With ketoacidosis
0.000 0.147 0.853
E10.2 With renal complications
0.000 0.157 0.843
L40.1 Generalised pustular psoriasis
0.842 0.158 0.000
L40.8 Other psoriasis
0.831 0.169 0.000
E06 Thyroiditis
0.000 0.188 0.812
E55 Vitamin D deficiency
0.000 0.190 0.810
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.195 0.805
E10.6 With other specified complications
0.000 0.208 0.792
E05.8 Other thyrotoxicosis
0.000 0.217 0.783
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.220 0.780
E16 Other disorders of pancreatic internal secretion
0.000 0.223 0.777
E55.9 Vitamin D deficiency, unspecified
0.000 0.259 0.741
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
L40.4 Guttate psoriasis
0.717 0.283 0.000
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.1 Congenital hypothyroidism without goitre
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E53 Deficiency of other B group vitamins
0.000 0.284 0.716
E10.7 With multiple complications
0.000 0.284 0.716
E10.0 With coma
0.000 0.284 0.716
E16.2 Hypoglycaemia, unspecified
0.000 0.290 0.710
E12 Malnutrition-related diabetes mellitus
0.000 0.294 0.706
E61 Deficiency of other nutrient elements
0.000 0.301 0.699
E10.8 With unspecified complications
0.000 0.321 0.678
E06.3 Autoimmune thyroiditis
0.000 0.323 0.677
E07.1 Dyshormogenetic goitre
0.000 0.343 0.657
E07.0 Hypersecretion of calcitonin
0.000 0.343 0.657
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.351 0.649
E63 Other nutritional deficiencies
0.000 0.351 0.649
E56 Other vitamin deficiencies
0.000 0.351 0.649
E51 Thiamine deficiency
0.000 0.351 0.649
E50 Vitamin A deficiency
0.000 0.351 0.649
E60 Dietary zinc deficiency
0.000 0.351 0.649
E59 Dietary selenium deficiency
0.000 0.351 0.649
E58 Dietary calcium deficiency
0.000 0.351 0.649
E54 Ascorbic acid deficiency
0.000 0.351 0.649
E52 Niacin deficiency [pellagra]
0.000 0.351 0.649
E03.8 Other specified hypothyroidism
0.000 0.357 0.643
E15 Nondiabetic hypoglycaemic coma
0.000 0.380 0.619
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.389 0.611
E06.9 Thyroiditis, unspecified
0.000 0.417 0.583
E06.5 Other chronic thyroiditis
0.000 0.417 0.582
E06.4 Drug-induced thyroiditis
0.000 0.417 0.582
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.417 0.582
E06.1 Subacute thyroiditis
0.000 0.417 0.582
E06.0 Acute thyroiditis
0.000 0.417 0.582
E13 Other specified diabetes mellitus
0.000 0.419 0.581
E53.8 Deficiency of other specified B group vitamins
0.000 0.419 0.581
E55.0 Rickets, active
0.000 0.419 0.581
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.443 0.557
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.443 0.557
E16.4 Abnormal secretion of gastrin
0.000 0.443 0.557
E16.3 Increased secretion of glucagon
0.000 0.443 0.557
E61.1 Iron deficiency
0.000 0.450 0.550
E65-E68 Obesity and other hyperalimentation
0.000 0.459 0.541
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E53.9 Vitamin B deficiency, unspecified
0.000 0.486 0.514
E53.1 Pyridoxine deficiency
0.000 0.486 0.514
E53.0 Riboflavin deficiency
0.000 0.486 0.514
E16.1 Other hypoglycaemia
0.000 0.492 0.507
E12.9 Without complications
0.000 0.493 0.506
E12.8 With unspecified complications
0.000 0.493 0.506
E12.7 With multiple complications
0.000 0.493 0.506
E12.6 With other specified complications
0.000 0.493 0.506
E12.5 With peripheral circulatory complications
0.000 0.493 0.506
E12.4 With neurological complications
0.000 0.493 0.506
E12.3 With ophthalmic complications
0.000 0.493 0.506
E12.2 With renal complications
0.000 0.493 0.506
E12.1 With ketoacidosis
0.000 0.493 0.506
E12.0 With coma
0.000 0.493 0.506
E07.8 Other specified disorders of thyroid
0.000 0.495 0.504
E40-E46 Malnutrition
0.001 0.498 0.501
E61.9 Deficiency of nutrient element, unspecified
0.000 0.499 0.501
E61.8 Deficiency of other specified nutrient elements
0.000 0.499 0.501
E61.7 Deficiency of multiple nutrient elements
0.000 0.499 0.501
E61.6 Vanadium deficiency
0.000 0.499 0.501
E61.5 Molybdenum deficiency
0.000 0.499 0.501
E61.4 Chromium deficiency
0.000 0.499 0.501
E61.3 Manganese deficiency
0.000 0.499 0.501
E61.2 Magnesium deficiency
0.000 0.499 0.501
E61.0 Copper deficiency
0.000 0.499 0.501
E50.9 Vitamin A deficiency, unspecified
0.000 0.534 0.465
E50.8 Other manifestations of vitamin A deficiency
0.000 0.534 0.465
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.534 0.465
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.534 0.465
E50.5 Vitamin A deficiency with night blindness
0.000 0.534 0.465
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.534 0.465
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.534 0.465
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.534 0.465
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.534 0.465
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.534 0.465
E51.9 Thiamine deficiency, unspecified
0.000 0.534 0.465
E51.8 Other manifestations of thiamine deficiency
0.000 0.534 0.465
E51.2 Wernicke's encephalopathy
0.000 0.534 0.465
E51.1 Beriberi
0.000 0.534 0.465
E56.9 Vitamin deficiency, unspecified
0.000 0.534 0.465
E56.8 Deficiency of other vitamins
0.000 0.534 0.465
E56.1 Deficiency of vitamin K
0.000 0.534 0.465
E56.0 Deficiency of vitamin E
0.000 0.534 0.465
E63.9 Nutritional deficiency, unspecified
0.000 0.534 0.465
E63.8 Other specified nutritional deficiencies
0.000 0.534 0.465
E63.1 Imbalance of constituents of food intake
0.000 0.534 0.465
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.534 0.465
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.534 0.465
E64.8 Sequelae of other nutritional deficiencies
0.000 0.534 0.465
E64.3 Sequelae of rickets
0.000 0.534 0.465
E64.2 Sequelae of vitamin C deficiency
0.000 0.534 0.465
E64.1 Sequelae of vitamin A deficiency
0.000 0.534 0.465
E64.0 Sequelae of protein-energy malnutrition
0.000 0.534 0.465
E13.8 With unspecified complications
0.000 0.583 0.417
E13.7 With multiple complications
0.000 0.583 0.417
E13.6 With other specified complications
0.000 0.583 0.417
E13.5 With peripheral circulatory complications
0.000 0.583 0.417
E13.4 With neurological complications
0.000 0.583 0.417
E13.3 With ophthalmic complications
0.000 0.583 0.417
E13.2 With renal complications
0.000 0.583 0.417
E13.1 With ketoacidosis
0.000 0.583 0.417
E13.0 With coma
0.000 0.583 0.417
E67 Other hyperalimentation
0.000 0.612 0.388
E68 Sequelae of hyperalimentation
0.000 0.612 0.388
E04 Other non-toxic goitre
0.000 0.625 0.375
K90 Intestinal malabsorption
0.000 0.633 0.367
E14 Unspecified diabetes mellitus
0.000 0.637 0.363
E44 Protein-energy malnutrition of moderate and mild degree
0.001 0.640 0.359
E45 Retarded development following protein-energy malnutrition
0.001 0.640 0.359
E43 Unspecified severe protein-energy malnutrition
0.001 0.640 0.359
E42 Marasmic kwashiorkor
0.001 0.640 0.359
E41 Nutritional marasmus
0.001 0.640 0.359
E40 Kwashiorkor
0.001 0.640 0.359
M07.30 Other psoriatic arthropathies (Multiple sites)
0.349 0.651 0.000
M07.3 Other psoriatic arthropathies
0.348 0.652 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.342 0.658 0.000
E65 Localised adiposity
0.000 0.678 0.322
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.319 0.681 0.000
E66 Obesity
0.000 0.681 0.319
T43.2 Other and unspecified antidepressants
0.318 0.682 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.304 0.696 0.000
M07.34 Other psoriatic arthropathies (Hand)
0.303 0.697 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.300 0.700 0.000
E14.3 With ophthalmic complications
0.000 0.701 0.299
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.707 0.293
E13.9 Without complications
0.000 0.708 0.292
T43.4 Butyrophenone and thioxanthene neuroleptics
0.290 0.710 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.289 0.711 0.000
E66.8 Other obesity
0.000 0.712 0.288
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.286 0.714 0.000
E67.8 Other specified hyperalimentation
0.000 0.721 0.278
E67.3 Hypervitaminosis D
0.000 0.721 0.278
E67.2 Megavitamin-B6 syndrome
0.000 0.721 0.278
E67.1 Hypercarotenaemia
0.000 0.721 0.278
E67.0 Hypervitaminosis A
0.000 0.721 0.278
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.278 0.722 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.278 0.722 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.276 0.724 0.000
T43.6 Psychostimulants with abuse potential
0.270 0.730 0.000
E20-E35 Disorders of other endocrine glands
0.000 0.730 0.270
E04.8 Other specified non-toxic goitre
0.000 0.731 0.269
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.266 0.734 0.000
K90.3 Pancreatic steatorrhoea
0.000 0.737 0.263
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.737 0.263
K90.1 Tropical sprue
0.000 0.737 0.263
E14.7 With multiple complications
0.000 0.740 0.260
E14.5 With peripheral circulatory complications
0.000 0.740 0.260
E14.2 Withrenal complications
0.000 0.740 0.260
E14.0 With coma
0.000 0.740 0.260
E44.1 Mild protein-energy malnutrition
0.001 0.742 0.258
E44.0 Moderate protein-energy malnutrition
0.001 0.742 0.258
E14.8 With unspecified complications
0.000 0.745 0.254
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.253 0.747 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.749 0.251
M07.38 Other psoriatic arthropathies (Other)
0.250 0.750 0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.250 0.750 0.000
M07.33 Other psoriatic arthropathies (Forearm)
0.250 0.750 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.250 0.750 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.250 0.750 0.000
E14.6 With other specified complications
0.000 0.755 0.244
K90.9 Intestinal malabsorption, unspecified
0.000 0.758 0.242
E14.1 With ketoacidosis
0.000 0.760 0.240
L40-L45 Papulosquamous disorders
0.238 0.762 0.000
E04.1 Non-toxic single thyroid nodule
0.000 0.762 0.238
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.237 0.762 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.237 0.763 0.000
E04.0 Non-toxic diffuse goitre
0.000 0.763 0.237
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.231 0.768 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.230 0.770 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.229 0.771 0.000
T43.9 Psychotropic drug, unspecified
0.229 0.771 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.229 0.771 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.229 0.771 0.000
E66.1 Drug-induced obesity
0.000 0.771 0.229
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.227 0.773 0.000
E27 Other disorders of adrenal gland
0.000 0.775 0.225
T43.3 Phenothiazine antipsychotics and neuroleptics
0.223 0.777 0.000
E27.1 Primary adrenocortical insufficiency
0.000 0.781 0.218
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.218 0.782 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.218 0.782 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.218 0.782 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.218 0.782 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.783 0.217
T36 Poisoning by systemic antibiotics
0.217 0.783 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.215 0.784 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.215 0.784 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.215 0.784 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.215 0.784 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.215 0.784 0.000
T44.0 Anticholinesterase agents
0.215 0.784 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.212 0.788 0.000
E14.4 With neurological complications
0.000 0.788 0.211
T47.4 Other laxatives
0.210 0.790 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.209 0.790 0.000
K90.8 Other intestinal malabsorption
0.000 0.794 0.206
T46 Poisoning by agents primarily affecting the cardiovascular system
0.201 0.799 0.000
E34 Other endocrine disorders
0.000 0.800 0.200
T45.0 Antiallergic and antiemetic drugs
0.195 0.805 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.806 0.193
E32 Diseases of thymus
0.000 0.806 0.193
E31 Polyglandular dysfunction
0.000 0.806 0.193
E30 Disorders of puberty, not elsewhere classified
0.000 0.806 0.193
E25 Adrenogenital disorders
0.000 0.806 0.193
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.191 0.809 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.191 0.809 0.000
T47.7 Emetics
0.191 0.809 0.000
T47.6 Antidiarrhoeal drugs
0.191 0.809 0.000
T47.5 Digestants
0.191 0.809 0.000
T47.3 Saline and osmotic laxatives
0.191 0.809 0.000
T47.2 Stimulant laxatives
0.191 0.809 0.000
T47.0 Histamine H(2)-receptor antagonists
0.191 0.809 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.187 0.813 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.187 0.813 0.000
E26 Hyperaldosteronism
0.000 0.818 0.182
E20 Hypoparathyroidism
0.000 0.818 0.182
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.182 0.818 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.182 0.818 0.000
T42.3 Barbiturates
0.182 0.818 0.000
T42.2 Succinimides and oxazolidinediones
0.182 0.818 0.000
E29 Testicular dysfunction
0.000 0.818 0.181
E66.0 Obesity due to excess calories
0.000 0.821 0.178
T42.4 Benzodiazepines
0.178 0.822 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.178 0.822 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.178 0.822 0.000
E22 Hyperfunction of pituitary gland
0.000 0.823 0.177
E28 Ovarian dysfunction
0.000 0.823 0.177
T38.1 Thyroid hormones and substitutes
0.175 0.825 0.000
T42.1 Iminostilbenes
0.174 0.826 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.827 0.173
L42 Pityriasis rosea
0.171 0.828 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.172 0.828 0.000
L44 Other papulosquamous disorders
0.171 0.829 0.000
L41 Parapsoriasis
0.171 0.829 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.171 0.829 0.000
T38.9 Other and unspecified hormone antagonists
0.170 0.829 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.170 0.829 0.000
T38.7 Androgens and anabolic congeners
0.170 0.829 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.170 0.829 0.000
T38.5 Other oestrogens and progestogens
0.170 0.829 0.000
T38.4 Oral contraceptives
0.170 0.829 0.000
T38.2 Antithyroid drugs
0.170 0.829 0.000
T38.0 Glucocorticoids and synthetic analogues
0.170 0.829 0.000
T42.0 Hydantoin derivatives
0.167 0.833 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.164 0.836 0.000
T45.8 Other primarily systemic and haematological agents
0.164 0.836 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.164 0.836 0.000
T45.6 Fibrinolysis-affecting drugs
0.164 0.836 0.000
T45.4 Iron and its compounds
0.164 0.836 0.000
T45.3 Enzymes, not elsewhere classified
0.164 0.836 0.000
T45.2 Vitamins, not elsewhere classified
0.164 0.836 0.000
E27.8 Other specified disorders of adrenal gland
0.000 0.837 0.163
T50.8 Diagnostic agents
0.163 0.837 0.000
T50.7 Analeptics and opioid receptor antagonists
0.163 0.837 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.163 0.837 0.000
T50.5 Appetite depressants
0.163 0.837 0.000
T50.4 Drugs affecting uric acid metabolism
0.163 0.837 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.163 0.837 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.163 0.837 0.000
T50.1 Loop [high-ceiling] diuretics
0.163 0.837 0.000
T50.0 Mineralocorticoids and their antagonists
0.163 0.837 0.000
E27.5 Adrenomedullary hyperfunction
0.000 0.839 0.161
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.839 0.161
E27.0 Other adrenocortical overactivity
0.000 0.839 0.161
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.156 0.843 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.156 0.843 0.000
T37.5 Antiviral drugs
0.156 0.843 0.000
T37.4 Anthelminthics
0.156 0.843 0.000
T37.3 Other antiprotozoal drugs
0.156 0.843 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.156 0.843 0.000
T37.1 Antimycobacterial drugs
0.156 0.843 0.000
T37.0 Sulphonamides
0.156 0.843 0.000
T41.5 Therapeutic gases
0.156 0.843 0.000
T41.4 Anaesthetic, unspecified
0.156 0.843 0.000
T41.3 Local anaesthetics
0.156 0.843 0.000
T41.2 Other and unspecified general anaesthetics
0.156 0.843 0.000
T41.1 Intravenous anaesthetics
0.156 0.843 0.000
T41.0 Inhaled anaesthetics
0.156 0.843 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.156 0.843 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.156 0.843 0.000
T48.5 Anti-common-cold drugs
0.156 0.843 0.000
T48.4 Expectorants
0.156 0.843 0.000
T48.3 Antitussives
0.156 0.843 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.156 0.843 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.156 0.843 0.000
T48.0 Oxytocic drugs
0.156 0.843 0.000
T49.9 Topical agent, unspecified
0.156 0.843 0.000
T49.8 Other topical agents
0.156 0.843 0.000
T49.7 Dental drugs, topically applied
0.156 0.843 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.156 0.843 0.000
T49.5 Ophthalmological drugs and preparations
0.156 0.843 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.156 0.843 0.000
T49.3 Emollients, demulcents and protectants
0.156 0.843 0.000
T49.2 Local astringents and local detergents
0.156 0.843 0.000
T49.1 Antipruritics
0.156 0.843 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.156 0.843 0.000
T36.9 Systemic antibiotic, unspecified
0.156 0.844 0.000
T36.8 Other systemic antibiotics
0.156 0.844 0.000
T36.7 Antifungal antibiotics, systemically used
0.156 0.844 0.000
T36.6 Rifamycins
0.156 0.844 0.000
T36.5 Aminoglycosides
0.156 0.844 0.000
T36.4 Tetracyclines
0.156 0.844 0.000
T36.3 Macrolides
0.156 0.844 0.000
T36.2 Chloramphenicol group
0.156 0.844 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.156 0.844 0.000
E46 Unspecified protein-energy malnutrition
0.002 0.844 0.154
T36.0 Penicillins
0.155 0.845 0.000
T39.0 Salicylates
0.154 0.846 0.000
R41.0 Disorientation, unspecified
0.000 0.846 0.154
M07 Psoriatic and enteropathic arthropathies
0.150 0.850 0.000
E34.9 Endocrine disorder, unspecified
0.000 0.851 0.149
E27.2 Addisonian crisis
0.000 0.851 0.149
E04.2 Non-toxic multinodular goitre
0.000 0.851 0.149
T46.5 Other antihypertensive drugs, not elsewhere classified
0.148 0.852 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.148 0.852 0.000
E24 Cushing's syndrome
0.000 0.853 0.147
T46.4 Angiotensin-converting-enzyme inhibitors
0.146 0.854 0.000
E34.0 Carcinoid syndrome
0.000 0.855 0.145
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.144 0.856 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.144 0.856 0.000
T46.7 Peripheral vasodilators
0.144 0.856 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.144 0.856 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.144 0.856 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.144 0.856 0.000
E34.5 Androgen resistance syndrome
0.000 0.856 0.143
E34.4 Constitutional tall stature
0.000 0.856 0.143
E34.3 Short stature, not elsewhere classified
0.000 0.856 0.143
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.856 0.143
E34.1 Other hypersecretion of intestinal hormones
0.000 0.856 0.143
E34.8 Other specified endocrine disorders
0.000 0.857 0.143
E21.0 Primary hyperparathyroidism
0.000 0.859 0.141
T39.1 4-Aminophenol derivatives
0.141 0.859 0.000
E22.1 Hyperprolactinaemia
0.000 0.860 0.139
E25.9 Adrenogenital disorder, unspecified
0.000 0.861 0.139
E25.8 Other adrenogenital disorders
0.000 0.861 0.139
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.861 0.139
E30.9 Disorder of puberty, unspecified
0.000 0.861 0.139
E30.8 Other disorders of puberty
0.000 0.861 0.139
E30.1 Precocious puberty
0.000 0.861 0.139
E30.0 Delayed puberty
0.000 0.861 0.139
E31.9 Polyglandular dysfunction, unspecified
0.000 0.861 0.139
E31.8 Other polyglandular dysfunction
0.000 0.861 0.139
E31.1 Polyglandular hyperfunction
0.000 0.861 0.139
E31.0 Autoimmune polyglandular failure
0.000 0.861 0.139
E32.9 Disease of thymus, unspecified
0.000 0.861 0.139
E32.8 Other diseases of thymus
0.000 0.861 0.139
E32.1 Abscess of thymus
0.000 0.861 0.139
E32.0 Persistent hyperplasia of thymus
0.000 0.861 0.139
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.861 0.139
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.861 0.139
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.861 0.139
T46.1 Calcium-channel blockers
0.137 0.863 0.000
T39.4 Antirheumatics, not elsewhere classified
0.134 0.866 0.000
T39.2 Pyrazolone derivatives
0.134 0.866 0.000
E28.3 Primary ovarian failure
0.000 0.867 0.133
E26.9 Hyperaldosteronism, unspecified
0.000 0.869 0.131
E26.8 Other hyperaldosteronism
0.000 0.869 0.131
E26.1 Secondary hyperaldosteronism
0.000 0.869 0.131
E20.8 Other hypoparathyroidism
0.000 0.869 0.130
E20.1 Pseudohypoparathyroidism
0.000 0.869 0.130
E20.0 Idiopathic hypoparathyroidism
0.000 0.869 0.130
E29.9 Testicular dysfunction, unspecified
0.000 0.870 0.130
E29.8 Other testicular dysfunction
0.000 0.870 0.130
E29.0 Testicular hyperfunction
0.000 0.870 0.130
E21.3 Hyperparathyroidism, unspecified
0.000 0.872 0.128
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.127 0.872 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.873 0.127
E22.8 Other hyperfunction of pituitary gland
0.000 0.873 0.127
E28.9 Ovarian dysfunction, unspecified
0.000 0.873 0.127
E28.8 Other ovarian dysfunction
0.000 0.873 0.127
E28.1 Androgen excess
0.000 0.873 0.127
E28.0 Oestrogen excess
0.000 0.873 0.127
E21.4 Other specified disorders of parathyroid gland
0.000 0.876 0.124
E21.2 Other hyperparathyroidism
0.000 0.876 0.124
L41.9 Parapsoriasis, unspecified
0.123 0.877 0.000
L41.8 Other parapsoriasis
0.123 0.877 0.000
L41.5 Retiform parapsoriasis
0.123 0.877 0.000
L41.4 Large plaque parapsoriasis
0.123 0.877 0.000
L41.3 Small plaque parapsoriasis
0.123 0.877 0.000
L41.2 Lymphomatoid papulosis
0.123 0.877 0.000
L41.1 Pityriasis lichenoides chronica
0.123 0.877 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.123 0.877 0.000
L44.9 Papulosquamous disorder, unspecified
0.123 0.877 0.000
L44.8 Other specified papulosquamous disorders
0.123 0.877 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.123 0.877 0.000
L44.3 Lichen ruber moniliformis
0.123 0.877 0.000
L44.2 Lichen striatus
0.123 0.877 0.000
L44.1 Lichen nitidus
0.123 0.877 0.000
L44.0 Pityriasis rubra pilaris
0.123 0.877 0.000
E26.0 Primary hyperaldosteronism
0.000 0.880 0.120
E20.9 Hypoparathyroidism, unspecified
0.000 0.881 0.119
E29.1 Testicular hypofunction
0.000 0.882 0.118
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.889 0.111
E22.0 Acromegaly and pituitary gigantism
0.000 0.889 0.111
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.111 0.889 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.890 0.110
E24.2 Drug-induced Cushing's syndrome
0.000 0.891 0.109
M07.6 Other enteropathic arthropathies
0.107 0.892 0.000
M07.5 Arthropathy in ulcerative colitis
0.107 0.892 0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.107 0.892 0.000
M07.2 Psoriatic spondylitis
0.107 0.892 0.000
M07.1 Arthritis mutilans
0.107 0.892 0.000
M07.0 Distal interphalangeal psoriatic arthropathy
0.107 0.892 0.000
E24.8 Other Cushing's syndrome
0.000 0.894 0.106
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.894 0.106
E24.3 Ectopic ACTH syndrome
0.000 0.894 0.106
E24.1 Nelson's syndrome
0.000 0.894 0.106
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.103 0.896 0.000
E27.9 Disorder of adrenal gland, unspecified
0.001 0.898 0.101
T45.5 Anticoagulants
0.101 0.899 0.001
E28.2 Polycystic ovarian syndrome
0.000 0.899 0.101
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.900 0.100
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.914 0.086
E24.9 Cushing's syndrome, unspecified
0.000 0.915 0.085
E24.0 Pituitary-dependent Cushing's disease
0.001 0.916 0.084
L43 Lichen planus
0.081 0.918 0.001
R41 Other symptoms and signs involving cognitive functions and awareness
0.000 0.920 0.080
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.079 0.920 0.000
T40.8 Lysergide [LSD]
0.079 0.920 0.000
T40.7 Cannabis (derivatives)
0.079 0.920 0.000
T40.5 Cocaine
0.079 0.920 0.000
T40.3 Methadone
0.079 0.920 0.000
T40.1 Heroin
0.079 0.920 0.000
T40.0 Opium
0.079 0.920 0.000
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.077 0.923 0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.077 0.923 0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.077 0.923 0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.077 0.923 0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.077 0.923 0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)
0.077 0.923 0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm
0.077 0.923 0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm
0.077 0.923 0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region
0.077 0.923 0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)
0.077 0.923 0.000
M07.19 Arthritis mutilans (Site unspecified)
0.077 0.923 0.000
M07.18 Arthritis mutilans (Other)
0.077 0.923 0.000
M07.17 Arthritis mutilans (Ankle and foot)
0.077 0.923 0.000
M07.16 Arthritis mutilans (Lower leg)
0.077 0.923 0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)
0.077 0.923 0.000
M07.14 Arthritis mutilans (Hand)
0.077 0.923 0.000
M07.13 Arthritis mutilans (Forearm)
0.077 0.923 0.000
M07.12 Arthritis mutilans (Upper arm)
0.077 0.923 0.000
M07.11 Arthritis mutilans (Shoulder region)
0.077 0.923 0.000
M07.10 Arthritis mutilans (Multiple sites)
0.077 0.923 0.000
M07.29 Psoriatic spondylitis (Site unspecified)
0.077 0.923 0.000
M07.28 Psoriatic spondylitis (Other)
0.077 0.923 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.